Top Banner
ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital and Medical Center, Englewood, New Jersey Clinical Professor of Anesthesiology, Medicine and Surgery Mount Sinai School of Medicine, New York
45

ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Dec 11, 2015

Download

Documents

Stacy Fancy
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ACUTE NORMOVOLEMIC HEMODILUTIONAryeh Shander, MD, FCCM, FCCP

Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine

Englewood Hospital and Medical Center,Englewood, New Jersey

Clinical Professor of Anesthesiology, Medicine and SurgeryMount Sinai School of Medicine, New York

Page 2: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ANH

• The technique• Formula or other targets• Fluid resuscitation, is there a

difference?• Induced anemia – safe or risk?• Anemia, perfusion and organ

function• ANH and PBM- outcomes

Page 3: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ANH

• As a blood conservation technique it cannot stand alone and must be accompanied by– Treatment of ANEMIA– Cell salvage and possible fractionation– Post operative management of anemia

and coagulation

Page 4: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ANH – The Debate

• ANH – controversial• ANH – variety of methods• ANH – unclear indications• ANH – risk not quantified• ANH – more work

Page 5: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Acute Normovolemic Acute Normovolemic Hemodilution (ANH)Hemodilution (ANH)

ANHANHNormovolemicHemodilution

NormovolemicHemodilution

Surgery(1- 6 hours)

Surgery(1- 6 hours)

He

mo

glo

bin

(g

/dL

)

14

11

8

5

PostoperativePostoperative

Page 6: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ANHANH

Page 7: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.
Page 8: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Practical Issues

• ANH– Key Points:

•Vascular access - IV or arterial•Monitoring•GA and/or Regional•Fluid replacement

Page 9: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ANH indications and concerns• Relative Indications

•Preop normal Hemoglobin levels•Anticipated intraop blood loss > ~1000ml•Moderate anticipated blood loss in patient

refusing allogeneic transfusion•Ability to draw blood after anesthetic induction

+ before commencement of surgical bleeding• Concerns

– Ability to tolerate blood withdrawal– Recurarization* (Br J Anaesth. 2006;97(4):482-8)– Coagulation– Fluid overload

Hobisch-Hagen P et al. BJA;82(4):503-9

Page 10: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Outcome Measurement in Blood Conservation (ANH)

• Reduced blood loss– Statistically significant reduction of blood loss– Clinically significant reduction of blood loss

• Reduced blood loss and or eliminate patient’s exposure to allogeneic transfusions

• Reduced or eliminate transfusions alone• Morbidity – perioperative infection, SIRS or MOF• Mortality

Page 11: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

The Effect of Two Levels of Hypotension on Intraoperative Blood Loss During Total Hip

Arthroplasty Performed Under Lumber Epidural

Anesthesia

Shanrrock NE, et al.Anesth Analg. 1993 Mar;76(3):580-4.

Page 12: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Intraoperative – ANHEffectiveness of acute normovolemic

hemodilution to minimize allogeneic blood transfusion in major liver resections

• Liver resection – at least 30% transfusion requirements

• Prospective, randomized• N = 78• ANH to target Hct 24% vs. controls• Transfuse at 20% Matot I, et al.

Anesthesiology 2002;97:794-800.

Page 13: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Intraoperative – ANHIntraoperative – ANH

36

10

0

5

10

15

20

25

30

35

40

Control ANH

% t

ran

sfu

se

d a

llog

en

eic

blo

od

Matot I. et al. Anesthesiology 2002;97:794-800

Page 14: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ANH

• The technique• Formula or other targets• Fluid resuscitation, is there a

difference?• Induced anemia – what’s the limit?• Anemia, perfusion and organ function• ANH and blood conservation -

outcomes

Page 15: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

V=EBV x Hi – Hf / Hav

ANH

Page 16: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

                                                                                                                         

Weiskopf R.B. Anesthesiology 2001;94:439-46

Page 17: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ANH

• The technique• Formula or other targets• Fluid resuscitation, is there a

difference?• Induced anemia – what’s the limit?• Anemia, perfusion and organ function• ANH and blood conservation -

outcomes

Page 18: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Choice of Fluid

• Crystalloid• ‘Normal’ Saline• Physiologic solutions

• Colloid• HA• Penta-Starch• Solute

Page 19: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Normal Saline vs. LR in Gyn Surgery

Total n = 24

Scheingraber et al. Anesthesiology 1999

Page 20: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Anemia, viscosity and tissue oxygenation

OX

YG

EN

TE

NS

ION

, mm

/hg

Tsai AG. Tsai AG. Biorheology 38 (2000) 229-237Biorheology 38 (2000) 229-237

Page 21: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Acid-Base Changes Caused by 5% Albumin versus 6% Hydroxyl Starch Solution in Patients Undergoing ANHRehm M, et. Al. Anesthesiology 2000;93:1174-83

• N=20 Gyn surgery • ANH to HCT 22%• 10 HES and 10 HA in NaCl solution• Blood volume well maintained in

both groups• Metabolic acidosis (SID) with both

after ANH

Page 22: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ANH

• The technique• Formula or other targets• Fluid resuscitation, is there a

difference?• Induced anemia – safe or risk?• Anemia, perfusion and organ function• ANH and blood conservation -

outcomes

Page 23: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

VO2 vs. DO2

DO2 ml/m2/min

VO2

Critical point of DO2

E.C.S.M. van Woerkens A&A 75, 1992

Page 24: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Normovolemic Anemia N=33

Weiskopf et.al. JAMA 279, #3 1998

Page 25: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Critical Oxygen Delivery in Conscious Humans

0

5

10

15

Esmolol Hemodilution Baseline

timetime

DO2

andVO2

ml O2 Kg-1

min-1

N=8N=8Hb. 4.7+/- 0.2 g/dlHb. 4.7+/- 0.2 g/dl

Lieberman JA Lieberman JA AnesthesiologyAnesthesiology 2000; 92:407-13 2000; 92:407-13

****

Page 26: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ANH & Coagulation

• aPT, INR, aPTT, platelets and fibrinogen• No significant change at 500, 1000 ml• 1500 ml, aPT and INR increased without

increased in nonsurgical bleeding

Page 27: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Figure 1: Coagulation Studies in ANH

60

70

80

90

100

110

120

130

Baseline 1000cc 1500 cc

% o

f Cha

nge

Platelets

Fibgn.

INR

PT

PTT

Hemoglobin

Page 28: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

TEG values in ANH

0

10

20

30

40

50

60

70

80

pre-ANH post-ANH post return

mm

/ d

eg

. R

K

MA

Ang

Page 29: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Acute Severe Isovolemic Anemia Impairs Cognitive Function and Memory in Humans

Weiskopf R.B. et.al., Anesthesiology 2000;92:1646-1652 N=9 volunteers - reaction time and calculation

were impaired at Hb of 5.0gm/dl but not 7.0gm/dl

No PET scan, tests 10-15 min after anemia induction

Impaired vs. protectiveOxygen Reverses Deficits of Cong. Function

and Memory and Increased Heart Rate Induced by Acute Severe Isovolemic Anemia

Weiskopf R.B. et.al. Anesthesiology 2002;96:871-877

Acute Isovolemic Anemia Does Not Impair Peripheral or Central Nerve Conduction

Weiskopf R.B., et.al. Anesthesiology 2003;99(3):546-551

Peripheral conduction but no CNS effect at 5.0gm/dl

Page 30: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Cardiovascular Disease

Page 31: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Coronary Flow• Flow resistance is primarily reduced by

reduction of viscosity• Coronary flow is markedly increased with

ANH - Subendo and Subepicardial, improved oxygen utilization– Increased myocardial O2 extraction– Active coronary vasodilatation– MVO2 (myocardial BF X CaO2) remain stable

• Extraction ratio in severe ANH is UNCHANGED until Hct drops below 12.5% (Hgb 4.5)

Jan KM, Am J Physiol 1977;233:H106Levy PS et al. Am J Physiol 1993;265:H340-9

Page 32: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Cardioprotective effects of acute normovolemic hemodilution in patients with

severe aortic stenosis undergoing valve replacement

• N = 40 patients scheduled for elective AVR - randomly assigned to a control group (standard care) or an ANH group (target hematocrit level of 28%)

• In the ANH group:– Postoperative release of troponin I (1.7 ng/mL) and myocardial fraction

of creatine kinase (22 U/L) was significantly lower than in the control group (3.6 ng/mL and 45 [U/L, respectively)

– Circulating levels of erythropoietin (EPO) were higher than in control patients (13.6 +/- 4.2 mUI/mL vs. 7.3 +/- 2.4 mUI/mL; p < 0.05).

• Fewer hemodiluted patients presented adverse cardiac events

• Preoperative ANH further attenuates myocardial injuries• ANH-induced cardioprotection:

– Optimization of preischemic myocardial oxygen delivery and/or consumption

– Postconditioning effects of endogenous EPOLicker M. et al. Transfusion. 2007 Feb;47(2):341-50

Page 33: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Perioperative time course of serum concentrations of total CPK (A), CK-MB (B), and cTnI (C) in the control ( ) and ANH ( )

groups. *p < 0.05, between the two groups; #p < 0.05, compared with baseline

Licker M. et al. Transfusion. 2007 Feb;47(2):341-50

Page 34: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

ANH & CARDIAC DISEASE

Anh.jpg

Page 35: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Significant Intraoperative Predictors of TransfusionBased on Patients With a Preoperative Estimated Risk of

Transfusion 5%a

Risk Factors OR CI Multivariate p Value

CPB time 1.013 1.005–1.020 0.001No. of bypass grafts (3) 0.381 0.138–1.052 0.0626Total crystalloid (2,500 mL) 4.732 1.181–18.961 0.0282

Total ANH 0.999 0.998–0.999 0.0049

n 145 observations; 5 were excluded because of missing values for acovariate; Hosmer-Lemeshow statistic for lack of fit of this model has a p

value of 0.72, and the c statistic 0.802.ANH acute normovolemic hemodilution; CI confidence interval;

Moskowitz D, Klein J.J, Shander A et.al. Ann Thorac Surg 2004;77:626–34

Page 36: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Blood ConservationEnglewood Hospital and Medical Center

Page 37: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

CABG OutcomesPBMP vs Non-PBMP

Moskowitz et al Ann Thorac Surg 2010

N=586

Page 38: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Outcome of ANH• Cost effective

– Monk TG, et al. Transfusion 1996;36(6):849-50ANH cost effective vs PAD in rad prostate surgery– Monk TG, et al. A&A 1997;85(5):953-8ANH replaces PAD– Monk TG, et al. Anesthesiology 1999;(1):24-33EPO, ANH and PAD – ANH least costly– Goodnough LT, et al. Vox Sang 1999;77(1):11-6RT of ANH vs PAD TKA – ANH less costly– Goodnough LT, et al. Transfsion

2000;40(9):1054-7RT ANH vs PAD in THA – ANH less $$

Page 39: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Clinical Studies

Meta-analysis of 24 randomized prospective studies of ANH in 1,218 patients

ANH reduced likelihood of allogeneic exposure and total units of allogeneic blood transfused

Bryson, G. L. et al., Anesth Analg 1998, 86: 9

Page 40: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Evaluation of Acute Normovolemic Hemodilution and Autotransfusion in

Neurosurgical Patients Undergoing Excision of Intracranial Meningiom

• Prospective randomized study• N = 40 (over 2 years)• Group I (Control Group) - Group II (ANH Group)

– Surgical blood loss in group I was 835.29 ± 684.37 ml vs 865 + 409.78 ml in group II

– Mean blood transfused in group I was 864.71 ± 349.89 ml vs. 165 ± 299.6 ml in group II [statistically significant (p<0.05)]

• ANH up to a target hematocrit of 30% is safe and effective in reducing the need for allogeneic blood

Naqash IA. Et al. J Anaesthesiol Clin Pharmacol. 2011 Jan;27(1):54-8

Page 41: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Relationship Between Intraoperative Fluid Administration and Perioperative Outcome After

Pancreaticoduodenectomy Management

• N = 130 (July 2005 to May 2009) randomized to ANH or standard management (STDM)– Transfusion rates were similar (ANH = 16.9%, 30 units vs STD =

18.5%, 33 units; P = 0.82)– Morbidity (ANH = 49.2% vs STD = 47%, P = 0.86)– More grade-3 complications in patients undergoing ANH (32% vs

23.1% STD, P = 0.17)– Pancreatic anastomosis complications higher in the ANH group

(21.5% vs 7.7%, P = 0.045)

• ANH did not reduce allogeneic transfusions• Restrictive intravenous fluid management

during PD may help improve postoperative outcome

Fischer M. et al. Ann Surg. 2010 Dec;252(6):952-8

Page 42: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controlled trial

• N = 155 patients undergoing elective hip surgery • Groups "ANH" (n = 78) or "standard transfusion" (n

= 77)• Allogeneic transfusion was necessary in 22 (29%)

standard transfusion patients and 15 (19%) ANH patients

• Postoperative complications:– 30 (38%) standard transfusion patients compared with 14

(18%) assigned to ANH group (OR, 0.3; 95% CI, 0.14-0.65; p = 0.009)

• The major difference between the groups was the frequency of infective complications

• ANH reduced postoperative complicationsBennett J. et al. Transfusion. 2006 Jul;46(7):1097-103

Page 43: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

Acute Normovolemic Hemodilution (ANH)

• Safely reduces allogeneic transfusions and associated complications

• Cost effective procedure • Effective in all surgical procedures –

method dependent • Dramatically underutilized• No standard approach to date

Page 44: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.
Page 45: ACUTE NORMOVOLEMIC HEMODILUTION Aryeh Shander, MD, FCCM, FCCP Chief, Department of Anesthesiology, Critical Care and Hyperbaric Medicine Englewood Hospital.

THANK YOU